UPDATE: B.Riley Starts Compass Therapeutics (CMPX) at Buy
Tweet Send to a Friend
(Updated - January 19, 2022 6:01 AM EST)
B.Riley analyst Justin Walsh initiates coverage on Compass Therapeutics (NASDAQ: CMPX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
B.Riley analyst Justin Walsh initiates coverage on Compass Therapeutics (NASDAQ: CMPX) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
